Similar companies View All
| Company | Instagram Followers | |
|---|---|---|
 |
AmgenAMGN |
26,447 0.1% |
 |
Thermo Fisher ScientificTMO |
69,772 0.1% |
 |
Bionano GenomicsBNGO |
3,956 0% |
 |
23andMeME |
139,787 0% |
 |
NovartisNVS |
121,632 0% |
Month over Month
Followers on Instagram.
| Oct 2024 | 12,522 | |
| Sep 2024 | 12,369 | |
| Aug 2024 | 12,295 | |
| Jul 2024 | 12,240 | |
| Jun 2024 | 12,194 |
How many followers does Illumina have on Instagram?
Illumina has 12,567 followers on Instagram.
Analyzing Instagram Followers, how is Illumina performing compared to its industry peers?
Illumina underperforms its industry peers when it comes to Instagram Followers, ranking in the 8th percentile.
How has Illumina's Instagram following changed in the last month?
In the last month, Illumina's Instagram following has increased by 0.9%. This positive growth indicates a strengthening online presence and growing brand interest.
How does Illumina's Instagram following contribute to its brand strength and influence in the market?
With tens of thousands of followers, Illumina's Instagram account is well-established, reaching a significant number of people. This demonstrates an increasing influence and the ability to captivate a broader audience, which is essential for developing a brand and enhancing online engagement.
Why should an investor in Illumina track and monitor Instagram Followers?
Monitoring Illumina's Instagram followers is crucial for investors to assess brand health and customer engagement. An increasing follower count suggests growing public interest and positive brand perception, which can favorably impact the company's market position. Conversely, a decline in followers might indicate waning consumer interest or negative sentiment, potentially signaling challenges in Illumina's outreach or strategy. This metric, in conjunction with financial and operational data, provides a more comprehensive view of Illumina's overall performance and future prospects.
Sign up and get more insights on Illumina and Instagram.
